Print view

Hepatitis B Vaccination of Adults

The Advisory Committee on Immunization Practices (ACIP) recommends hepatitis B (HepB) vaccination among all adults aged 19–59 years and adults > 60 years with risk factors for hepatitis B or without identified risk factors but seeking protection.


The Advisory Committee on Immunization Practices (ACIP) recommends that the following people should receive hepatitis B vaccination:

  • All infants
  • Unvaccinated children aged <19 years
  • Adults aged 19 through 59 years
  • Adults aged 60 years and older with risk factors for hepatitis B

The following groups may receive hepatitis B vaccination:

  • Adults aged 60 years and older without known risk factors for hepatitis B

Risk factors for hepatitis B

  • Persons at risk for infection by sexual exposure
    • Sex partners of persons who test positive for hepatitis B surface antigen (HBsAg)
    • Sexually active persons who are not in a long-term, mutually monogamous relationship (e.g., persons with more than one sex partner during the previous 6 months)
    • Persons seeking evaluation or treatment for a sexually transmitted infection
    • Men who have sex with men
  • Persons at risk for infection by percutaneous or mucosal exposure to blood
    • Persons with current or recent injection use
    • Household contacts of persons who test positive for HBsAg
    • Residents and staff of facilities for persons with developmental disabilities
    • Health care and public safety personnel with reasonably anticipated risk for exposure to blood or blood-contaminated body fluids
    • Persons on maintenance dialysis, including in-center or home hemodialysis and peritoneal dialysis, and persons who are predialysis
    • Persons with diabetes at the discretion of the treating clinician
  • Others
    • International travelers to countries with high or intermediate levels of endemic hepatitis B virus (HBV) infection (HBsAg prevalence of ≥2%)
    • Persons with hepatitis C virus infection
    • Persons with chronic liver disease (including, but not limited to, persons with cirrhosis, fatty liver disease, alcoholic liver disease, autoimmune hepatitis, or an alanine aminotransferase [ALT] or aspartate aminotransferase [AST] level greater than twice the upper limit of normal)
    • Persons with HIV infection
    • Incarcerated persons

Readthe whole article here.

  Quelle: (02.05.2023 - LW)
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichische Akademie der ÄrzteÄrzte der WeltÖsterreichische Gesellschaft für Public HealthHelix - Forschung & Beratung WienÄrztekammer für WienEuropean Public Health Association (EUPHA)Swiss Tropical and Public Health InstituteOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation